The world cancer-treating drugs market is expected to grow at a CAGR of 6.6% in the second half of the forecast period 2017-2027

LONDON, Nov. 8, 2017 /PRNewswire/ -- Immunotherapy, Chemotherapy, Targeted Therapy, Hormone Therapy, Leading Drugs

Report Details



Download the full report: https://www.reportbuyer.com/product/5184208


The world cancer-treating drugs market is expected to grow at a CAGR of 6.6% in the second half of the forecast period. The market reached $102bn in 2016, dominated by the immunotherapy segment which held 44.1% share of the market.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new 194-page report you will receive 110 tables and 101 figures – all unavailable elsewhere.
The 194-page report provides clear detailed insight into the world cancer-treating drugs market. Discover the key drivers and challenges affecting the market.
By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope
• World cancer-treating drugs market forecasts from 2017-2027

This report also breaks down the revenue forecast for the world cancer-treating drugs market by its leading segments:
- Immunotherapy
- Chemotherapy
- Targeted Therapy
- Hormone Therapy

Each sector is analysed and revenue forecasts presented.

This report discusses and forecasts revenues of the top 25 anti-cancer drugs:
- Avastin
- Herceptin
- Rituxan
- Gleevec
- Revlimid
- Alimta
- Velcade
- Erbitux
- Gardasil
- Zytiga
- Xeloda
- Tarceva
- Afinitor
- Sprycel
- Tasigna
- Sutent
- Nexavar
- Xgeva
- Zoladex
- Yervoy
- Vidaza
- Treanda
- Temodar
- Faslodex
- Abraxane
- Others

This report provides individual revenue forecasts to 2027 for these regional and national markets:
- North America: US, Canada, Mexico
- South America: Brazil, Argentina, Paraguay, Brazil, Rest of South America
- Europe: The UK, Germany, France, Spain, Italy, Rest of Europe
- Asia-Pacific: China, Japan, India, Australia, Thailand, Rest of Asia-Pacific
- Rest of World: Middle East, Africa, Other Countries
• This report discusses trends in the industry and assesses strengths and weaknesses, as well as opportunities and threats (SWOT). It also analyses social, technological, economic and political factors (STEP) that influence the cancer-treating drugs market

Our study discusses the selected leading companies that are the major players in the cancer-treating drugs market:
- AstraZeneca
- Merck & Co., Inc. (Merck)
- Novartis
- Amgen
- Bristol-Myers Squibb (BMS)
- GlaxoSmithKline (GSK)
- Johnson & Johnson (J&J)
- Roche
- Eli Lilly
- Celgene

The report provides overviews of the companies, financial information, product portfolio, pipeline products and recent developments.
Visiongain's study is intended for anyone requiring commercial analyses for the world cancer-treating drugs market. You find data, trends and predictions.
Buy our report today World Cancer-Treating Drugs Market Forecast 2017-2027: Immunotherapy, Chemotherapy, Targeted Therapy, Hormone Therapy, Leading Drugs.

Download the full report: https://www.reportbuyer.com/product/5184208

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
https://www.reportbuyer.com

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: query@reportbuyer.com
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

View original content:http://www.prnewswire.com/news-releases/the-world-cancer-treating-drugs-market-is-expected-to-grow-at-a-cagr-of-66-in-the-second-half-of-the-forecast-period-2017-2027-300552460.html

SOURCE ReportBuyer